Aaron Goodman: Toxicities to remember for Antibody Drug Conjugates
Aaron Goodman, Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, shared on X:
“Toxicities to remember for Antibody Drug Conjugates
Gemtuzumab ozogamicin = VOD
Inotuzumab ozogamicin = VOD
Brentuximab vedotin = Neuropathy
Polatuzumab vedotin = Neuropathy
Belantamab mafodotin = Blindness (keratopathy)
Moxetumomab pasudotox-tdfk = HUS+capillary leak
Loncastuximab tesirine = hepatitis.”
More posts featuring Aaron Goodman.
Aaron Goodman is a Hematologist/Oncologist and an Associate Professor of Medicine at the University of California, San Diego. He is a member of the National Comprehensive Cancer Network (NCCN) guideline committee for both cutaneous NHLs and T-cell NHLs. Dr. Goodman is a well-known physician-scientist, educator, advocate, and social media influencer.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023